Research

Overview

The Pediatric Pulmonology, Allergy and Immunology Division's research spans both basic science and translational approaches, with a strong emphasis on improving outcomes for our youngest and most vulnerable patients through innovative therapies, longitudinal care and multidisciplinary collaboration. We are growing our clinical research efforts, particularly with respiratory disease. We actively participate in multicenter clinical trials focused on pediatric pulmonary diseases, allowing us to contribute to and benefit from collaborative, practice-changing research. These studies help advance evidence-based care and give our patients access to cutting-edge therapies and innovations.

We have a strong focus on optimizing care for children with complex respiratory conditions, such as asthma, bronchiectasis and rare pulmonary tumors, while addressing real-world barriers to treatment, including medication delivery and adherence. Several studies highlight the integration of emerging technologies, such as digital inhalers and impulse oscillometry, as tools for improving diagnosis and management. We also evaluate new and existing pharmaceutical therapies, including FDA approvals and the pharmacokinetics of vitamin D in children with obesity-related asthma.

As part of the University of Louisville School of Medicine Pediatric Research Institute and Norton Children's Research Institute, our faculty and fellows can access cutting-edge research resources with minimal administrative burdens. With over 200 clinical research professionals and 300+ active studies, including Phase 1-3 clinical trials, we are at the forefront of pediatric research and clinical advancements.